Synertec has raised its FY27 revenue guidance by $8.0 million to $8.3 million, pointing to stronger contract conversion and visibility across its Engineering and Powerhouse businesses. The upgrade follows the $45.5 million ANSTO nuclear medicine manufacturing contract, but covers revenue only and not earnings or cash flow.
- FY27 revenue guidance lifted to $37.5 million-$40.0 million
- Upgrade represents 77%-89% growth on FY26 external revenue
- ANSTO contract contributes to, but does not solely drive, the upgrade
- Engineering and Powerhouse businesses provide the broader momentum
- No FY27 EBITDA, EBIT, NPAT or operating cash flow guidance
FY27 Revenue Range Moves Above $37 Million
Synertec Corporation Limited (ASX:SOP) has lifted its FY27 revenue guidance to $37.5 million-$40.0 million, up from the previous range of $29.5 million-$31.7 million. The revised range implies growth of approximately 77% to 89% on FY26 external revenue of $21.1 million.
The increase is worth $8.0 million to $8.3 million against the earlier guidance. Synertec attributed the upgrade to stronger contract conversion, completed project mobilisation and improved revenue visibility across both its Engineering and Powerhouse businesses.
ANSTO Award Supports Pipeline Conversion
The recently announced $45.5 million ANSTO Nuclear Medicine Manufacturing Program contract is a prominent contributor, but Synertec said it is not the sole reason for the higher outlook. The company also pointed to activity across government, healthcare, nuclear and critical infrastructure markets, alongside commercial progress in Powerhouse.
Synertec said the ANSTO award increased its previously disclosed $174 million Engineering pipeline by only about $9 million because much of the opportunity had already been included under its probability-weighted reporting approach. The company described the successful conversion as validation of the pipeline's quality and a source of increased confidence in further opportunities across both businesses.
Revenue Guidance Leaves Earnings Unquantified
The announcement provides no FY27 guidance for EBITDA, EBIT, NPAT or operating cash flow. That leaves the financial effect of the revenue upgrade unresolved: the filing indicates more work is expected to flow through the business, but does not quantify the associated margins, costs or cash generation.
The revised range assumes contracted work proceeds in line with current schedules, recently awarded projects are mobilised and executed, Powerhouse projects continue to progress, and revenue is recognised according to existing execution assumptions. It also depends on there being no material adverse changes in customer schedules, delivery timing, economic conditions, supply chains or foreign exchange rates.
The next test is therefore operational rather than headline-driven: whether Synertec can convert the enlarged order book and pipeline into recognised revenue within FY27 while providing clearer evidence of the earnings and cash-flow profile behind that growth.
Bottom Line?
The guidance upgrade materially raises Synertec's FY27 revenue bar, but the next reporting milestones will need to show how much of that growth reaches profit and cash flow.
Questions in the middle?
- How quickly will the ANSTO program move from mobilisation into recognised FY27 revenue?
- What margins and cash conversion will accompany the upgraded revenue range?
- How much further contract conversion will come from the Engineering and Powerhouse pipelines?